Guidelines/Position Statements
Appropriate Use Criteria
2024 | – | ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery |
2023 | – | ACC/ |
2020 | – | ACC/ |
2019 | – | ACC/ |
2017 | – | ACC/ |
2017 | – | ACC/ |
Other Documents
2024 | – | JACC Imaging Pericardial Consensus Paper | ||||||||||||||
2024 | – | Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From ASE Developed in Collaboration With SCMR and SCCT | ||||||||||||||
2023 | – | CMR for Evaluation of Cardiac Involvement in COVID-19: Recommendations by SCMR | ||||||||||||||
2022 | – | SCMR recommendations for training and competency of CMR technologists | ||||||||||||||
2022 | – | 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper | ||||||||||||||
2020 | – | SCMR Recommended CMR Protocols for Scanning Patients with Active or Convalescent Phase COVID-19 Infection | ||||||||||||||
2019 | – | Cardiac Magnetic Resonance Stress Perfusion Imaging for Evaluation of Patients With Chest Pain | ||||||||||||||
2018 | – | Expert consensus for CMR imaging endpoints in clinical research: part I – analytical validation and clinical qualification | ||||||||||||||
2018 | – | Guidelines for training in cardiovascular magnetic resonance (CMR) | ||||||||||||||
2018 | – | The Growth and Evolution of Cardiovascular Magnetic Resonance: 20-Year History of the SCMR Annual Scientific Sessions | ||||||||||||||
2017 | – | Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines | ||||||||||||||
2017 | – | Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology | ||||||||||||||
2017 | – | 2017 HRS Expert Consensus Statement on Magnetic Resonance Imaging and Radiation Exposure in Patients with Cardiovascular Implantable Electronic Devices | ||||||||||||||
2014 | – | Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Cardiovascular Magnetic Resonance Update
| ||||||||||||||
2014 | – | Simplifying Cardiovascular Magnetic Resonance Pulse Sequence Terminology
| ||||||||||||||
2012 | – | Heart Valve Disease: Investigation By Cardiovascular Magnetic Resonance
| ||||||||||||||
2012 | – | The Diagnosis of Hypertrophic Cardiomyopathy by Cardiovascular Magnetic Resonance
| ||||||||||||||
2012 | – | CMR in Inflammatory Vasculitis
| ||||||||||||||
2009 | – | Cardiovascular Magnetic Resonance in Pericardial Disease
|
Policies
The Society for Cardiovascular Magnetic Resonance (SCMR) recognizes that the shocking events in the United States and subsequent global #BlackLivesMatter protests, have a profound impact in our communities. Read More.
The Society for Cardiovascular Magnetic Resonance (SCMR) is deeply concerned about the escalating humanitarian crisis in the heart of Europe and the safety of the people of Ukraine.
The Society for Cardiovascular Magnetic Resonance (SCMR) is dedicated to ensuring the integrity of our research-related activities. Therefore, we work to responsibly identify and manage financial conflicts of interest (FCOI). Read More about our FCOI policy and the ways that we comply with the federal Public Health Service’s (PHS) requirements for institutions that seek research funding.